• 1
    Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet Med 1990; 7: 360.
  • 2
    The Lancet (editorial) putting feet first in diabetes. Lancet 2005; 366: 1674.
  • 3
    Van Houtum WH, Lavery LA. Outcomes associated with diabetes related amputations in the Netherlands and in the state of California, USA. J Intern Med 1996; 240: 227231.
  • 4
    Wrobel JS, Mayfield JA, Reiber GE. Geographic variation of lower extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care 2001; 24: 860864.
  • 5
    Fosse S, Hartemann-Heurtier A, Jacqueminet S, Ha Van G, Grimaldi A, Fagot-Campagna A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med 2009; 26: 391396.
  • 6
    Johannesson A, Larsson GU, Ramstrand N, Turkiewicz A, Wirehn AB, Atroshi I. Incidence of lower limb amputation in the diabetic and non-diabetic general population: a 10-year population-based cohort study of initial unilateral, contralateral and re-amputations. Diabetes Care 2009; 32: 275280.
  • 7
    Gershater MA, Löndahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009; 52: 398407.
  • 8
    Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008; 51: 747755.
  • 9
    Robbins JM, Strauss G, Aron D, Long J, Kuba J, Kaplan Y. Mortality rates and diabetic foot ulcers. Is it time to communicate mortality risk to patients with diabetic foot ulceration? J Am Podiat Med Assn 2008; 98(6): 489493.
  • 10
    Van Baal J, Hubbard R, Game F, Jeffcoate W. Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care 2010; 33: 10861089.
  • 11
    Morbach S, Furchert H, Gröblinghoff U, Hoffmeier H, Klauke GT, Klemp U, Rümenapf G, Gruessner A, Bharara M, Bhatnaga SA, Armstrong DG. Long-term prognosis of diabetic foot patients and their limbs: a 10-year analysis. Data presented at 6th International Symposium of the Diabetic Foot, May 2011. [15 June 2011].
  • 12
    Ghanassia E, Villon L, Dieudonne J-FT, Boegner C, Avignon A, Sultan A. Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers. A 6.5-year follow-up study. Diabetes Care 2008; 31: 12881292.
  • 13
    Taylor SM, Kalbaugh CA, Blackhurst DW, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients. J Vasc Surg 2005; 42: 227235.
  • 14
    Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 2006; 29: 17841787.
  • 15
    The National Collaborating Centre for Cancer Diagnosis and management of metastatic malignant disease of unknown primary origin. Full Guideline July 2010. [15 June 2011].
  • 16
    Young MJ, McCardle JE, Randall LE, Barclay JI. Improved survival of diabetic foot ulcer patients 1995–2008. Possible impact of aggressive cardiovascular risk management. Diabetes Care 2008; 31: 21432147.
  • 17
    Wrobel JS, Charns MP, Diehr P, et al. The relationship between provider coordination and diabetes-related foot outcomes. Diabetes Care 2003; 26: 30423047.
  • 18
    Canavan RJ, Unwin NC, Kelly WF, Connolly VM. Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care. Continuous longitudinal monitoring using a standard method. Diabetes Care 2008; 31: 459463.
  • 19
    The NHS Atlas of variation in healthcare. November 2010 [15 June 2011].